Save
Comorbid depression in multiple sclerosis: cognitive and hippocampal impacts
Author(s): ,
S.M. Gold
Affiliations:
Department of Psychiatry, Charité – Universitätsmedizin Berlin, Berlin; Center for Molecular Neurobiology, Institute for Neuroimmunology and Multiple Sclerosis, Hamburg, Germany
,
M.-F. O'Connor
Affiliations:
Department of Psychology, University of Arizona, Tucson, CA; Department of Psychiatry, University of Arizona, Tucson, AZ
,
E. Lopez
Affiliations:
Department of Psychiatry
,
K. Smith
Affiliations:
Department of Neurology, Cedars-Sinai Medical Center
,
C. Yamakawa
Affiliations:
Department of Neurology, Cedars-Sinai Medical Center
,
B. Renner
Affiliations:
Department of Neurology, Cedars-Sinai Medical Center
,
J.K. Gahm
Affiliations:
USC Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, United States
,
Y. Shi
Affiliations:
USC Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, United States
N.L. Sicotte
Affiliations:
Department of Neurology, Cedars-Sinai Medical Center
ECTRIMS Online Library. Sicotte N. Oct 8, 2015; 116646; 524
Nancy Sicotte
Nancy Sicotte
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Discussion Forum (0)
Rate & Comment (0)
Abstract: 98

Type: Oral

Abstract Category: Neuropsychology

Depression is among the most common comorbidities in multiple sclerosis (MS) with a significant impact on quality of life and employment status. In addition, depression in MS is associated with poorer cognitive performance. Previous studies have shown selective subregional hippocampal atrophy, alterations in diurnal cortisol secretion patterns and cognitive impairment in MS patients with depressive symptoms, similar to those reported in idiopathic major depressive disorder (iMDD). However, the relationship of comorbid major depressive disorder in MS (MS+MDD) to iMDD has not been established. We performed structured interviews, detailed cognitive testing and obtained high resolution structural MR imaging in four subject cohorts (MS+MDD, MSonly, iMDD and healthy controls (HC)) to contrast comorbid MDD in MS with idiopathic MDD.

Method: A total of 105 subjects were enrolled at a single center. They underwent the structured clinical interview for psychiatric disorders (SCID) and a detailed neuropsychological testing battery. All subjects also had a complete neurological exam that included determination of the EDSS and MS Functional Composite (MSFC). High resolution structural brain MR imaging was collected on a 3T scanner. Brain volumes were obtained using an automated algorithm (FIRST) with correction for head size. Analysis of cognitive testing results were performed with adjustment for age and sex (ANCOVA) using percentile test scores.

Results: Both right and left total hippocampal volumes were significantly reduced in both MS patient groups (p < 0.01) compared to healthy controls. Hippocampal volume loss was most pronounced in the right hippocampus of the comorbid MS+MDD group. All patient groups (MS+MDD, MSonly, iMDD) demonstrated impaired verbal learning as compared to the healthy controls (ANCOVA p=0.009) with idiopathic MDD the most impaired. Delayed verbal memory (0.06) and processing speed (0.07) showed trends for group differences in the patients versus HC.

Conclusions: MS related MDD is associated with significant cognitive impairment and hippocampal volume loss. These effects share features with, but are distinct from, idiopathic MDD suggesting that different pathophysiological underpinnings may exist between these forms of major depressive disorder.

Disclosure:

Stefan Gold: Receives funding from the National MS Society, the German Federal Ministry of Education and Research (BMBF), and the German Research Foundation (DFG)

Mary-Frances O´Connor: Receives funding from the DANA foundation

Enrique Lopez: No disclosures

Cristina Yamakawa: No disclosures

Kimberly Smith: No disclosure

Brian Renner: No disclosures

Yonggang Shi: Receives funding from the National MS Society

Jin Kyu Gahm: No disclosures

Nancy L. Sicotte: Receives funding from the National MS Society

Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings